Home > Products > CD3 & EGFR
> Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (scFv-CH1/CL)
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-077)
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD3 antibody variable domain is fused to CH1 and the other scFv from an anti-EGFR antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (scFv-CH1/CL) (BSCC-077). Click the button below to contact us or submit your feedback about this product.